Skip to main content

New from Alpha BoardBrief: The Adolescence of Governance · Read the doctrineAlpha BoardBrief: The Adolescence of Governance · Read the doctrine

Learn More about Alpha institutional services

Back to Executive Profile

Alpha Profiles · Executive Profile

Chris Cabell, M.D.

Director at Inhibikase Therapeutics, Inc. (NASDAQ: IKT)

https://registry.alpha.ac/people/chris-cabell-m-d

CC

Record status

Verified facts: 13
Profile ownership: Pending
Verified record version: v0
Presentation version: Alpha editorial

Owner-supplied résumé and presentation fields remain distinct from independently verified Alpha Profile facts.

Generated 2026-09-25T09:34:56.060Z

Data as of 2026-09-25T09:34:54.513257+00:00

https://registry.alpha.ac/people/chris-cabell-m-d

Alpha provides independent evals, research, and intelligence for AI governance. We connect the boardroom with the AI ecosystem.

Email address

Solutions

Institute
Evals
Intelligence
Profiles
Council
Education

Explore

Events
Newsletter
About
Leadership

Access

Learn More about Alpha institutional services
Access & Availability
Contact
Privacy
Terms
Subscribe to Alpha BoardBrief

Governance is alpha.

© Alpha Governance PBC